943b Induction Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 TrialBrian G. Feagan, Aparna R. Parikh, W. Sandborn et al.|Gastroenterology|2012Cited by 43
P234 Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteersCatherine Milch, Irving H. Fox, T. Wyant et al.|Journal of Crohn s and Colitis|2012Cited by 7